Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Fumaric Acid | HCID 444972 | — |
| Reactant | HCID 25164163 | HCID 25164163 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | HCID 86662778 | HCID 86662778 | — |
Reaction Steps
250 mg ethyl 4-[4-[(2R)-3-[4-amino-3-chloro-5-(trifluoromethyl)phenyl]-1-oxo-2-[[[4-(1,2,4,5-tetrahydro-2-oxo-3H-1,3-benzodiazepin-3-yl)-1-piperidinyl]carbonyl]oxy]propyl]-1-piperazinyl]-piperidine-1-acetate (0.316 mmol) of are dissolved in 1 ml of ethanol at ambient temperature. The solution is heated to 80° C. and combined with a solution of 73 mg fumaric acid (0.631 mmol) in 2 ml of ethanol. The temperature is lowered by 5° C. every 30 minutes. The suspension formed is stirred for 12 hours at ambient temperature. The solid formed is filtered off, washed with ethanol and dried for 12 hours at 35° C.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08551987B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-02007d85b8b2458f96b98608856109e9 |
|---|
| Source note | uspto-grants-2013_10 |
|---|